Vanda Pharmaceuticals Wins Rare FDA Hearing on HETLIOZ Application for Jet Lag

AdComHETLIOZPositive

AI Analysis

Summary

Vanda Pharmaceuticals has been granted a rare FDA advisory committee hearing for its HETLIOZ application for jet lag treatment. This indicates FDA engagement on a potentially novel indication for the company's sleep disorder drug.

Outcome Details

FDA advisory committee hearing granted

Importance:7/10

Sentiment:

0.70

FDArare_diseaseHETLIOZadvisory_committee

Related Companies

$VNDA

Read the original article

Published by yahoo_finance on March 3, 2026 1:56 PM

Read Original